JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Immune Thrombocytopenia

Obligatory

Must not donate if:
Associated with malignancy

Discretionary

If underlying cause of thrombocytopenia or treatment given is not a contraindication, accept.  Refer to relevant DSG entry. Refer to designated clinical support officer if further advice required.

See if Relevant

Malignancy


If treated with immunoglobulin:
Immunoglobulin Therapy
Transfusion
 

If treated with plasma exchange:
Transfusion


If treated with immunosuppressive therapy:
Immunosuppression

Additional Information

Immune thrombocytopenia can be associated with malignancies, especially haematological malignancies such as chronic lymphocytic leukaemia.

Reason for Change

Amend the ‘Obligatory’ section, add ‘Discretionary’ and ‘Additional Information’ sections, add link to ‘immunoglobulin therapy’ and ‘malignancy’ entries.

Update Information

This entry was last updated in
TDSG-LD Edition 203, Release 44